In late 2015, Senator Ted Cruz introduced a bill to make more drugs available to Americans more quickly. Specifically, his idea would have the Food and Drug Administration approve products for which there is an unmet medical need if those drugs or devices were already approved by regulators in other “trusted” countries. To further cut red tape, the FDA would have just 30 days to make a decision.
So far, his bill has gone nowhere. Meanwhile, a new analysis finds the effort may have a limited impact.